FDA recall record

JCB Laboratories Cefuroxime, Ophthalmic Solution for Injection, 10 mg/mL, 0.3 mL single-use recall — FDA D-0246-2018

Subpotent Drug: The product is sub-potent prior to its 90-day beyond use date.

Class IIIclassification
D-0246-2018official record ID
Feb 7, 2018report date

Recall record at a glance

Official recordD-0246-2018
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmJCB Laboratories LLC
Report dateFeb 7, 2018
Recall initiation dateJan 24, 2018
Quantity6,510 syriges
LocationWichita, KS, United States

Official product description

Cefuroxime, Ophthalmic Solution for Injection, 10 mg/mL, 0.3 mL single-use syringe. This is a Compounded Drug, Hospital & Office Use Only, Not for Resale. Fagron Sterile Services/JCB Laboratories, 7335 W. 33rd St. N., Wichita, KS 67205

Why the product was recalled

Subpotent Drug: The product is sub-potent prior to its 90-day beyond use date.

Distribution information

Nationwide within USA

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.